BETADINE SOLN

Compare BETADINE SOLN  to:
Compare
Compare

Generic Name for BETADINE SOLN

Povidone-iodine 10%; liq; pads; swab sticks; prep sticks.

Legal Classification:

OTC

Pharmacological Class for BETADINE SOLN

Antimicrobial.

Manufacturer of BETADINE SOLN

Purdue Products L.P.

Indications for BETADINE SOLN

Surgical antiseptic.

Adults and Children:

Apply as needed.

Also:

Precautions for BETADINE SOLN

Extensive burns (absorption may occur).

Adverse Reactions for BETADINE SOLN

Local irritation, sensitization (rare).

How is BETADINE SOLN supplied?

Spray—3 oz
Soln—½ oz, 4 oz, 8 oz, pt, qt, gal
Swab sticks—1, 3 packs
Prep stick—600
PrepStick Plus—600
Scrub—4 oz, pt, qt, gal
Cleanser—4 oz

Related Disease:

Antiseptic~surgical
Cleansers

Related Resources

Restylane-L and Perlane-L dermal fillers approved

February 03, 2010

The FDA has approved Medicis' hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L.

Juvéderm XC dermal filler approved

February 02, 2010

The FDA has approved Juvéderm XC (hyaluronic acid and lidocaine [preservative-free] injectable gel, from Allergan) dermal filler for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (eg, nasolabial folds).

Microcyn Wound Care OTC launched

October 30, 2008

Microcyn Wound Care OTC (oxychlorine topical cleanser, from Oculus Innovative Sciences) is now available without a prescription for moistening absorbent wound dressings and cleaning minor cuts, minor burns, superficial abrasions, and minor skin irritations.

Neosalus Cream available for dermatitis

March 16, 2010

Quinnova announced the launch of Neosalus Cream, a non-steroidal anti-inflammatory cream for the treatment of various dermatoses (eg, atopic dermatitis, contact dermatitis, and hand eczema).

FDA warns of reduced Plavix efficacy in poor metabolizers

March 15, 2010

The FDA has notified healthcare professionals and patients that a Boxed Warning has been added to the Plavix (clopidogrel tablets, from Bristol-Myers Squibb and Sanofi) Prescribing Information to include information about reduced Plavix efficacy in patients who are poor metabolizers of Plavix.